UDK: 616.065

PHARMACOVIGILANCE IN YAROSLAVL REGION ON THE EXAMPLE OF ANTIBACTERIAL DRUGS

V.A. Mayevskaya1, K.V. Gorelov2, N.S. Korozina3, A.S. Stromova1

1 ФГБОУ ВО «Ярославский государственный медицинский университет» Министерства здравоохранения Российской Федерации, 2Федеральная служба по надзору в сфере здравоохранения; 3Департамент здравоохранения и фармации Ярославской области

Abstract

Good pharmacovigilance practices have been introduced for continuous and updated exchange of information on drug safety. The pharmacovigilance system provides continuous monitoring of medicines, which can reduce morbidity, mortality and costs to health care providers. The purpose of this study was to analyze the structure and information of spontaneous messages received by the Pharmacovigilance Center in the Yaroslavl Region in 2018–2020. The work was divided into 2 stages: collection of information and analytical stage. According to the Federal Service for Surveillance in Healthcare, today antibacterial drugs for systemic use occupy a leading position in the Pharmacovigilance database, which is also confirmed by the data of our study. Antibiotic use has been reported in more than 70 % of COVID-19 cases. Inappropriate antibiotic treatment for COVID-19 patients can lead to preventable complications, including increased bacterial resistance.

Keywords

pharmacovigilance, antibacterial drugs, drug monitoring.

Contacts

Маевская Виктория Александровна – аспирант 3-го курса кафедры клинической фармакологии, Ярославский государственный медицинский университет, e-mail: vikakomiss13@gmail.con